Govt expert panel recommends regular market approval for Covishield, Covaxin – ET HealthWorld

Govt expert panel recommends regular market approval for Covishield, Covaxin – ET HealthWorld

By Payal Banerjee New Delhi, An expert panel of India’s central drug authority on Wednesday…

View More Govt expert panel recommends regular market approval for Covishield, Covaxin – ET HealthWorld
Full market approval for Covaxin, Covishield: Expert panel to meet today – ET HealthWorld

Full market approval for Covaxin, Covishield: Expert panel to meet today – ET HealthWorld

The subject expert committee (SEC), a body under the Drugs Controller General of India (DCGI),…

View More Full market approval for Covaxin, Covishield: Expert panel to meet today – ET HealthWorld
Experts panel to review applications of Covovax & Corbevax jabs; Merck’s Covid drug today – ET HealthWorld

Experts panel to review applications of Covovax & Corbevax jabs; Merck’s Covid drug today – ET HealthWorld

A crucial meeting, which will deliberate on possibly granting emergency use authorisation (EUA) to Serum…

View More Experts panel to review applications of Covovax & Corbevax jabs; Merck’s Covid drug today – ET HealthWorld
Omicron driven third wave in India likely to peak in Feb: Covid Supermodel Panel – ET HealthWorld

Omicron driven third wave in India likely to peak in Feb: Covid Supermodel Panel – ET HealthWorld

Daily COVID-19 caseload in India that is currently around 7,500 infections is expected to increase…

View More Omicron driven third wave in India likely to peak in Feb: Covid Supermodel Panel – ET HealthWorld
Covid-19: Centre’s expert panel allows clinical trials for third dose of Covaxin – ET HealthWorld

Covid-19: Centre’s expert panel allows clinical trials for third dose of Covaxin – ET HealthWorld

The expert panel of India’s drug regulator, DCGI, has permitted Bharat Biotech to give a…

View More Covid-19: Centre’s expert panel allows clinical trials for third dose of Covaxin – ET HealthWorld